Replies to post #13602 on GTC Biotherapeutics (fka GTCB)

[read_this_n0w]

Thanks jesse, i concur

seeing dr cox past strategy, i cannot see him cooperating to one either...he wants to build gtcb as it is

And it still has a very bright future, they do need some money to bridge the time to past FDA approval so they can get news deals on proving of concept with the first fda approval

hostile takeover? Unlikely due to assests in the staff that are crucial to the technology

[keitern]

"IMHO a merger or stock swap is in the 60% range and Dew may be including that possibilty in his definition of a buyout"

Either of the above "in some style" would be included in the overall chances given I would think.

"but as a "soothsayer" his record is no better than any of the rest of ours."

My point was that Dew was not "soothsaying"; on the contrary, his exquisite command of odds and statistics make me view his estimate as something more than a guess.

[DewDiligence]

>Dew may be including that possibility in his definition of a buyout.<

I’m using the word buyout to include: i) any transaction in which shares of GTC are exchanged for cash or shares of another company; or ii) a reverse merger in which GTC shareholders keep their shares but end up owning less than half of equity in the merged company.